A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This open-label, two-arm, drug interaction study will investigate the effect of
co-administration of rifampin or itraconazole on the pharmacokinetics of GDC-0032 in healthy
volunteers. In Arm A, volunteers will receive GDC-0032 and rifampin; in Arm B, volunteers
will receive GDC-0032 and itraconazole. The anticipated time on study treatment is
approximately 30 days.